Photoporation of NK-92MI cells with biodegradable polydopamine nanosensitizers as a promising strategy for the generation of engineered NK cell therapies

Source
Applied Materials Today - ISSN 2352-9407-40 (2024) p. 1-14
Author(s)
    Charlotte Hinnekens, Aranit Harizaj, Dominika Berdecka, Ilke Aernout, Molood Shariati, Stefanie Peeters, Eva Lion, Stefaan C. De Smedt, Bart Vandekerckhove, Kevin Braeckmans, Juan C. Fraire

A co-culture model to study modulators of tumor immune evasion through scalable arrayed CRISPR-interference screens

Source
Frontiers in immunology - ISSN 1664-3224-15 (2024) p. 1-16
Author(s)
    Ramiro Martinez, Chiara Finocchiaro, Louis Delhaye, Fien Gysens, Jasper Anckaert, Wim Trypsteen, Maarten Versteven, Eva Lion, Sandra Van Lint, Karim Vermaelen, Eric James de Bony, Pieter Mestdagh

Designing and combining chimeric antigen receptors for improved cellular immunotherapy of hematological malignancies

Source
Antwerp, University of Antwerp, Faculty of Medicine and Health Sciences, 2024,239 p.
Author(s)

Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study

Source
PLoS ONE - ISSN 1932-6203-19:7 (2024) p. 1-15
Author(s)